Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate in respiratory disease (Japan, Phase 3)
jRCT2080223533Phase 3Completed
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fluticasone furoate + umeclidinium bromide + vilanterol trifenatate in bronchopulmonary diseases. Started May 2017; status: completed.
02
Drugs
fluticasone furoate + umeclidinium bromide + vilanterol trifenatate
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on jRCT2080223533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223533.